Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?

被引:19
作者
Papadakos, Stavros P. [1 ]
Dedes, Nikolaos [1 ]
Pergaris, Alexandros [1 ]
Gazouli, Maria [2 ]
Theocharis, Stamatios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Dept Pathol 1, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Lab Biol, Athens 11527, Greece
关键词
pancreatic cancer; exosomes; biomarkers; diagnosis; prognosis; therapy; MESENCHYMAL STROMAL CELLS; DUCTAL ADENOCARCINOMA; NAB-PACLITAXEL; RISK-FACTORS; STEM-CELLS; GEMCITABINE; CHEMORESISTANCE; IMMUNOTHERAPY; ASSOCIATION; RESISTANCE;
D O I
10.3390/ijms23073620
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic Ductal Adenocarcinoma (PDAC) constitutes a leading cause of cancer death globally. Its mortality remains unaltered despite the considerable scientific progress made in the fields of diagnostics and treatment. Exosomes comprise of small extracellular vesicles secreted by nearly all cells; their cargo contains a vast array of biomolecules, such as proteins and microRNAs. It is currently established that their role as messengers is central to a plethora of both physiologic and pathologic processes. Accumulating data have shed light on their contributions to carcinogenesis, metastasis, and immunological response. Meanwhile, the advancement of personalized targeted therapies into everyday clinical practice necessitates the development of cost-efficient treatment approaches. The role of exosomes is currently being extensively investigated towards this direction. This review aims to summarize the current pre-clinical and clinical evidence regarding the effects of exosomal applications in the timely diagnosis, prognosis, and therapeutic management of pancreatic cancer.
引用
收藏
页数:17
相关论文
共 128 条
[51]   A comprehensive overview of exosomes as drug delivery vehicles - Endogenous nanocarriers for targeted cancer therapy [J].
Johnsen, Kasper Bendix ;
Gudbergsson, Johann Mar ;
Skov, Martin Najbjerg ;
Pilgaard, Linda ;
Moos, Torben ;
Duroux, Meg .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (01) :75-87
[52]  
JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412
[53]   The biology, function, and biomedical applications of exosomes [J].
Kalluri, Raghu ;
LeBleu, Valerie S. .
SCIENCE, 2020, 367 (6478) :640-+
[54]   Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer [J].
Kamerkar, Sushrut ;
LeBleu, Valerie S. ;
Sugimoto, Hikaru ;
Yang, Sujuan ;
Ruivo, Carolina F. ;
Melo, Sonia A. ;
Lee, J. Jack ;
Kalluri, Raghu .
NATURE, 2017, 546 (7659) :498-+
[55]   Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990S [J].
Karim-Kos, Henrike E. ;
de Vries, Esther ;
Soerjomataram, Isabelle ;
Lemmens, Valery ;
Siesling, Sabine ;
Coebergh, Jan Willem W. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (10) :1345-1389
[56]   Drugging all RAS isoforms with one pocket [J].
Kessler, Dirk ;
Bergner, Andreas ;
Boettcher, Jark ;
Fischer, Gerhard ;
Doebel, Sandra ;
Hinkel, Melanie ;
Muellauer, Barbara ;
Weiss-Puxbaum, Alexander ;
McConnell, Darryl B. .
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (21) :1911-1923
[57]   Drugging an undruggable pocket on KRAS [J].
Kessler, Dirk ;
Gmachl, Michael ;
Mantoulidis, Andreas ;
Martin, Laetitia J. ;
Zoephel, Andreas ;
Mayer, Moriz ;
Gollner, Andreas ;
Covini, David ;
Fischer, Silke ;
Gerstberger, Thomas ;
Gmaschitz, Teresa ;
Goodwin, Craig ;
Greb, Peter ;
Haring, Daniela ;
Hela, Wolfgang ;
Hoffmann, Johann ;
Karolyi-Oezguer, Jale ;
Knesi, Petr ;
Kornigg, Stefan ;
Koegl, Manfred ;
Kousek, Roland ;
Lamarre, Lyne ;
Moser, Franziska ;
Munico-Martinez, Silvia ;
Peinsipp, Christoph ;
Phan, Jason ;
Rinnenthal, Joerg ;
Sai, Jiqing ;
Salamon, Christian ;
Scherbantin, Yvonne ;
Schipany, Katharina ;
Schnitzer, Renate ;
Schrenk, Andreas ;
Sharps, Bernadette ;
Siszler, Gabriella ;
Sun, Qi ;
Waterson, Alex ;
Wolkerstorfer, Bernhard ;
Zeeb, Markus ;
Pearson, Mark ;
Fesik, Stephen W. ;
McConnell, Darryl B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (32) :15823-15829
[58]   CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy [J].
Kimura, Hirokazu ;
Yamamoto, Hideki ;
Harada, Takeshi ;
Fumoto, Katsumi ;
Osugi, Yoshihito ;
Sada, Ryota ;
Maehara, Natsumi ;
Hikita, Hayato ;
Mori, Soichiro ;
Eguchi, Hidetoshi ;
Ikawa, Masahito ;
Takehara, Tetsuo ;
Kikuchi, Akira .
CLINICAL CANCER RESEARCH, 2019, 25 (06) :1936-1947
[59]   Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy [J].
Kishimoto, Shun ;
Brender, Jeffrey R. ;
Chandramouli, Gadisetti V. R. ;
Saida, Yu ;
Yamamoto, Kazutoshi ;
Mitchell, James B. ;
Krishna, Murali C. .
ANTIOXIDANTS & REDOX SIGNALING, 2021, 35 (11) :904-915
[60]   Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone [J].
Koch, Raphael ;
Aung, Thiha ;
Vogel, Daniel ;
Chapuy, Bjoern ;
Wenzel, Dirk ;
Becker, Sabrina ;
Sinzig, Ursula ;
Venkataramani, Vivek ;
von Mach, Tobias ;
Jacob, Ralf ;
Truemper, Lorenz ;
Wulf, Gerald G. .
CLINICAL CANCER RESEARCH, 2016, 22 (02) :395-404